Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma

Korean Journal of Internal Medicine

Volumn 29, Issue 2, 2014, Pages 231-235

  Yang, Suh Yoon ^a   Cha, Bong Ki ^a   Kim, Gihyeon ^a   Lee, Hyun Woong ^a   Kim, Jae Gyu ^a   Chang, Sae Kyung ^a   Kim, Hyung Joon ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

Dermatomyositis; Hepatitis B virus; Hepatocellular carcinoma

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; HEMOGLOBIN; HEPATITIS B ANTIGEN; LACTATE DEHYDROGENASE; LAMIVUDINE; MUSCLE ENZYME; PREDNISOLONE; RO ANTIBODY; ANTIVIRUS AGENT; GLUCOCORTICOID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CREATINE KINASE BLOOD LEVEL; DERMATOMYOSITIS; DISEASE ASSOCIATION; DYSPHAGIA; ELECTROMYOGRAPHY; FACE ERYTHEMA; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; MUSCLE BIOPSY; MUSCLE LEVEL; MUSCLE WEAKNESS; PATHOGENESIS; PERIORBITAL EDEMA; POIKILODERMA; PORTAL VEIN THROMBOSIS; PROTHROMBIN TIME; RASH; SKIN MANIFESTATION; THROMBOCYTE COUNT; VIRUS DETECTION; BIOPSY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DISEASE COURSE; FATALITY; HEPATITIS B, CHRONIC; LIVER NEOPLASMS; PARANEOPLASTIC SYNDROMES; RISK FACTOR; TIME; TREATMENT OUTCOME; VIROLOGY;

ANTIVIRAL AGENTS; BIOPSY; CARCINOMA, HEPATOCELLULAR; DERMATOMYOSITIS; DISEASE PROGRESSION; FATAL OUTCOME; GLUCOCORTICOIDS; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84897866136     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2014.29.2.231     Document Type: Article

References (10)

1. Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol 2008;59:99-112.
2. Cheng TI, Tsou MH, Yang PS, Sung SM, Chuang VP, Sung JL. Dermatomyositis and erythrocytosis associated with hepatocellular carcinoma. J Gastroenterol Hepatol 2002;17:1239-1240.
3. Gomez A, Solans R, Simeon CP, et al. Dermatomyositis, hepatocarcinoma, and hepatitis C: comment on the article by Weidensaul et al. Arthritis Rheum 1997;40:394-395.
4. Inuzuka M, Tomita K, Tokura Y, Takigawa M. Acquired ichthyosis associated with dermatomyositis in a patient with hepatocellular carcinoma. Br J Dermatol 2001;144:416-417.
5. Kee KM, Wang JH, Lee CM, Changchien CS, Eng HL. Chronic hepatitis C virus infection associated with dermatomyositis and hepatocellular carcinoma. Chang Gung Med J 2004;27:834-839.
6. Toshikuni N, Torigoe R, Mitsunaga M, Omoto A, Nakashima K. Dermatomyositis associated with hepatocellular carcinoma in an elderly female patient with hepatitis C virus-related liver cirrhosis. World J Gastroenterol 2006;12:1641-1644.
7. Kee SJ, Kim TJ, Lee SJ, et al. Dermatomyositis associated with hepatitis B virus-related hepatocellular carcinoma. Rheumatol Int 2009;29:595-599.
8. Andras C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008;35:438-444.
9. Levine SM. Cancer and myositis: new insights into an old association. Curr Opin Rheumatol 2006;18:620-624.
10. Hengstman GJ, Vree Egberts WT, Seelig HP, et al. Clinical characteristics of patients with myositis and autoantibodies to different fragments of the Mi-2 beta antigen. Ann Rheum Dis 2006;65:242-245.